# Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.

> **NCT01405872** · — · COMPLETED · sponsor: **Biogen** · enrollment: 270 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** AVONEX PEN

## Key facts

- **NCT ID:** NCT01405872
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2014-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01405872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01405872, "Persistence, Adherence, Quality of Life, and Treatment Satisfaction With Avonex® PEN™.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01405872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
